Thank you for considering to present your work as a poster at this event.
Please prepare your poster in A1 portrait format (59cm wide x 84cm long). Please do not laminate your poster or use heavy printing material. Further information about poster sizes can be found on the following link:
Posters larger than A1 will only be displayed subject to the availability of space.
Maximum capacity 10 A1 potrait posters
Please ensure you have appropriate permissions for the publication of your abstract from the original copyright holders. Should you wish your abstract not to be published, please notify us in writing at the time of abstract submission.
Poster presenters will be required to send us their poster as PDF at least two weeks before the event. The posters will be made available via the event website or other electronic media after the event (see copyright terms).
Posters will be displayed for the full duration of the event. Titles of accepted poster abstracts will be displayed below.
(Presenters in Bold)
If your abstract has been accepted for presentation but it does not appear in the list below, please let us know as soon as possible by email on FluOxford@gmail.com.
Establishment of reference material for serology of Zika virus infection
James Ashall, Giada Mattiuzzo, Mark Hassall, Sophie Myhill, Mark Page, Stacey Efstathiou
Department of Virology, National Institute of Biological Standards and Controls, Potters Bar, Hertfordshire
Accurate diagnosis of Zika virus (ZIKV) infection is essential not only to minimise further transmission but also to improve the understanding of viral epidemiology. ZIKV is usually associated with mild symptoms however during the ongoing outbreak in South America, the rise of Zika-associated cases of microcephaly and neurological disorders has prompted the WHO to declare an epidemic of international concern. Serological tests are used for testing patients for zika infection due to short viraemia in plasma; however they generally lack specificity and struggle to differentiate between the closely related Dengue virus. This highlights the needs for specific reagents to assure assay performance…
Establishing a WHO International Reference Reagent for Ebola virus antigen
Sophie H Myhill1, Giada Mattiuzzo, Mark Page, James Ashall, Dianna Wilkinson, Gillian Cooper, Kaetan Ladhani and Stacey Efstathiou
Department of Virology, National Institute for Biological Standards and Control, Blanche Lane, Potters Bar, Hertfordshire, EN63QG, UK
NIBSC is developing an antigen Reference Reagent for Ebola virus (EBOV) to monitor the performance of diagnostic assays, as part of the World Health Organization’s (WHO) response to the 2013-2016 EBOV outbreak in Western Africa and to provision for any further outbreaks. While the preferred Ebola diagnostic assays used during the outbreak have been PCR-based methods, these could take up to 5 days from collection of the sample, transport to special facilities and analysis. At the clinic, to give a fast diagnosis to patients suspected of having Ebola virus infection, point of care (POC) tests would allow a more rapid, although less sensitive and less specific, alternative. To date, three POC antigen capture tests have approved for emergency deployment by the WHO, all based on the detection of EBOV viral protein 40 (VP40) as the target antigen…